{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:47:54Z","timestamp":1785797274809,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Startup Fund for scientific research of Fujian Medical University","award":["2024QH1149"],"award-info":[{"award-number":["2024QH1149"]}]},{"name":"the National Natural Science Foundation of Fujian Province","award":["No.2025J01829"],"award-info":[{"award-number":["No.2025J01829"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology of Fujian Province","award":["No. 2025Y9429"],"award-info":[{"award-number":["No. 2025Y9429"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82472058"],"award-info":[{"award-number":["82472058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0522802"],"award-info":[{"award-number":["2024ZD0522802"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54219-3","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T10:51:55Z","timestamp":1779706315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhenliang","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingliu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"5","key":"54219_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier, B. et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 30(5), 706\u2013720 (2019).","journal-title":"Ann Oncol."},{"issue":"11","key":"54219_CR2","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1464-410X.2008.07917.x","volume":"102","author":"L Zini","year":"2008","unstructured":"Zini, L. et al. Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma. BJU Int. 102(11), 1610\u20131614 (2008).","journal-title":"BJU Int."},{"issue":"8","key":"54219_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00345-016-1773-y","volume":"34","author":"S Dabestani","year":"2016","unstructured":"Dabestani, S. et al. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: A population-based study. World J. Urol. 34(8), 1081\u20131086 (2016).","journal-title":"World J. Urol."},{"issue":"2","key":"54219_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jso.23473","volume":"109","author":"P Paparel","year":"2014","unstructured":"Paparel, P. et al. Local recurrence after radical nephrectomy for kidney cancer: Management and prediction of outcomes. A multi-institutional study. J. Surg. Oncol. 109(2), 126\u2013131 (2014).","journal-title":"J. Surg. Oncol."},{"key":"54219_CR5","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15749","volume":"11","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. The novel role of LDHA\/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma. PeerJ 11, e15749 (2023).","journal-title":"PeerJ"},{"key":"54219_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-101","volume":"13","author":"H Girgis","year":"2014","unstructured":"Girgis, H. et al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol. Cancer 13, 101 (2014).","journal-title":"Mol. Cancer"},{"issue":"1","key":"54219_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.juro.2015.08.071","volume":"195","author":"H Fukushima","year":"2016","unstructured":"Fukushima, H., Nakanishi, Y., Kataoka, M., Tobisu, K. & Koga, F. Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma. J. Urol. 195(1), 26\u201332 (2016).","journal-title":"J. Urol."},{"issue":"5","key":"54219_CR8","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4103\/0366-6999.177001","volume":"129","author":"Y Song","year":"2016","unstructured":"Song, Y. et al. Impact of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma treated by targeted therapy. Chin Med J (Engl). 129(5), 530\u2013535 (2016).","journal-title":"Chin Med J (Engl)."},{"issue":"7","key":"54219_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3109\/0284186X.2015.1043026","volume":"54","author":"F Petrelli","year":"2015","unstructured":"Petrelli, F. et al. Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies. Acta Oncol. 54(7), 961\u2013970 (2015).","journal-title":"Acta Oncol."},{"key":"54219_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijsu.2019.10.043","volume":"72","author":"S Su","year":"2019","unstructured":"Su, S., Liu, L., Li, C., Zhang, J. & Li, S. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis. Int. J. Surg. 72, 146\u2013153 (2019).","journal-title":"Int. J. Surg."},{"issue":"3","key":"54219_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jamaoncol.2017.4771","volume":"4","author":"L Mezquita","year":"2018","unstructured":"Mezquita, L. et al. Association of the Lung Immune Prognostic Index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer. JAMA Oncol. 4(3), 351\u2013357 (2018).","journal-title":"JAMA Oncol."},{"key":"54219_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111713","author":"DE Meyers","year":"2019","unstructured":"Meyers, D. E. et al. The Lung Immune Prognostic Index discriminates survival outcomes in patients with solid tumors treated with immune checkpoint inhibitors. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers11111713 (2019).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"54219_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12885-021-09131-6","volume":"22","author":"L Li","year":"2022","unstructured":"Li, L. et al. High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansine. BMC Cancer 22(1), 29 (2022).","journal-title":"BMC Cancer"},{"key":"54219_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.972352","volume":"13","author":"X He","year":"2022","unstructured":"He, X. et al. Prognostic significance of modified lung immune prognostic index in osteosarcoma patients. Front. Genet. 13, 972352 (2022).","journal-title":"Front. Genet."},{"key":"54219_CR15","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.2147\/CMAR.S298412","volume":"13","author":"JF Feng","year":"2021","unstructured":"Feng, J. F., Zhao, J. M., Chen, S. & Chen, Q. X. Prognostic significance of the lung immune prognostic index in patients with resected esophageal squamous cell carcinoma. Cancer Manag. Res. 13, 2811\u20132819 (2021).","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"54219_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s10147-021-02059-8","volume":"27","author":"K Obayashi","year":"2022","unstructured":"Obayashi, K. et al. The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy. Int J Clin Oncol. 27(2), 396\u2013402 (2022).","journal-title":"Int J Clin Oncol."},{"key":"54219_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.1002075","volume":"9","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q., Deng, G., Wang, Z. & Dai, G. Preoperative lung immune prognostic index predicts survival in patients with pancreatic cancer undergoing radical resection. Front. Surg. 9, 1002075 (2022).","journal-title":"Front. Surg."},{"issue":"4","key":"54219_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/bjc.2012.292","volume":"107","author":"MJ Proctor","year":"2012","unstructured":"Proctor, M. J. et al. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 107(4), 695\u2013699 (2012).","journal-title":"Br J Cancer."},{"issue":"4","key":"54219_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg, B. et al. European Association of Urology guidelines on renal cell carcinoma: The 2022 update. Eur. Urol. 82(4), 399\u2013410 (2022).","journal-title":"Eur. Urol."},{"issue":"4","key":"54219_CR20","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/annonc\/mdw016","volume":"27","author":"PF Ferrucci","year":"2016","unstructured":"Ferrucci, P. F. et al. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: Prognostic relevance in metastatic melanoma patients receiving ipilimumab. Ann. Oncol. 27(4), 732\u2013738 (2016).","journal-title":"Ann. Oncol."},{"issue":"1","key":"54219_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/atm.2018.12.10","volume":"7","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z., Kim, H. J., Lonjon, G. & Zhu, Y. Balance diagnostics after propensity score matching. Ann Transl Med. 7(1), 16 (2019).","journal-title":"Ann Transl Med."},{"issue":"6","key":"54219_CR22","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","volume":"168","author":"I Frank","year":"2002","unstructured":"Frank, I. et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J. Urol. 168(6), 2395\u20132400 (2002).","journal-title":"J. Urol."},{"issue":"5","key":"54219_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.eururo.2018.01.005","volume":"73","author":"BC Leibovich","year":"2018","unstructured":"Leibovich, B. C. et al. Predicting oncologic outcomes in renal cell carcinoma after surgery. Eur. Urol. 73(5), 772\u2013780 (2018).","journal-title":"Eur. Urol."},{"issue":"23","key":"54219_CR24","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1200\/JCO.2002.05.111","volume":"20","author":"A Zisman","year":"2002","unstructured":"Zisman, A. et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J. Clin. Oncol. 20(23), 4559\u20134566 (2002).","journal-title":"J. Clin. Oncol."},{"key":"54219_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijsu.2020.05.019","volume":"79","author":"N Zhang","year":"2020","unstructured":"Zhang, N. et al. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis. Int J Surg. 79, 66\u201373 (2020).","journal-title":"Int J Surg."},{"issue":"1","key":"54219_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/his.13735","volume":"74","author":"B Delahunt","year":"2019","unstructured":"Delahunt, B., Eble, J. N., Egevad, L. & Samaratunga, H. Grading of renal cell carcinoma. Histopathology 74(1), 4\u201317 (2019).","journal-title":"Histopathology"},{"issue":"12","key":"54219_CR27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00345-018-2447-8","volume":"36","author":"AY Warren","year":"2018","unstructured":"Warren, A. Y. & Harrison, D. WHO\/ISUP classification, grading and pathological staging of renal cell carcinoma: Standards and controversies. World J. Urol. 36(12), 1913\u20131926 (2018).","journal-title":"World J. Urol."},{"issue":"6","key":"54219_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex, A. et al. European Association of Urology Guidelines on renal cell carcinoma: The 2025 update. Eur. Urol. 87(6), 683\u2013696 (2025).","journal-title":"Eur. Urol."},{"issue":"5","key":"54219_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.eururo.2004.07.002","volume":"46","author":"V Ficarra","year":"2004","unstructured":"Ficarra, V., Novara, G., Galfano, A. & Artibani, W. Neoplasm staging and organ-confined renal cell carcinoma: A systematic review. Eur. Urol. 46(5), 559\u2013564 (2004).","journal-title":"Eur. Urol."},{"issue":"12","key":"54219_CR30","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","volume":"7","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy. Cancer Med. 7(12), 6124\u20136136 (2018).","journal-title":"Cancer Med."},{"issue":"1","key":"54219_CR31","doi-asserted-by":"publisher","first-page":"1731942","DOI":"10.1080\/2162402X.2020.1731942","volume":"9","author":"S Van Wilpe","year":"2020","unstructured":"Van Wilpe, S. et al. Lactate dehydrogenase: a marker of diminished antitumor immunity. Oncoimmunology. 9(1), 1731942 (2020).","journal-title":"Oncoimmunology."},{"issue":"7203","key":"54219_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454(7203), 436\u2013444 (2008).","journal-title":"Nature"},{"issue":"2","key":"54219_CR33","doi-asserted-by":"publisher","first-page":"824","DOI":"10.21873\/invivo.13885","volume":"39","author":"K Shibata","year":"2025","unstructured":"Shibata, K. et al. Novel preoperative immune prognostic index for predicting outcomes in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. In Vivo 39(2), 824\u2013833 (2025).","journal-title":"In Vivo"},{"key":"54219_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu13114086","author":"JP Yoon","year":"2021","unstructured":"Yoon, J. P. et al. Comparison of preoperative nutritional indexes for outcomes after primary esophageal surgery for esophageal squamous cell carcinoma. Nutrients https:\/\/doi.org\/10.3390\/nu13114086 (2021).","journal-title":"Nutrients"},{"key":"54219_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114048","volume":"204","author":"L Carril-Ajuria","year":"2024","unstructured":"Carril-Ajuria, L. et al. Validation of the lung immune prognostic index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma. Eur. J. Cancer 204, 114048 (2024).","journal-title":"Eur. J. Cancer"},{"key":"54219_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040776","author":"Y Ishiyama","year":"2024","unstructured":"Ishiyama, Y., Kondo, T., Yoshida, K., Iizuka, J. & Takagi, T. Prognostic value of the Lung Immune Prognostic Index on recurrence after radical surgery for high-risk renal cell carcinoma. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers16040776 (2024).","journal-title":"Cancers (Basel)"},{"issue":"7","key":"54219_CR37","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/ijc.34793","volume":"154","author":"M Majdoub","year":"2024","unstructured":"Majdoub, M. et al. Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis. Int. J. Cancer 154(7), 1309\u20131323 (2024).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"54219_CR38","doi-asserted-by":"publisher","first-page":"50.e1","DOI":"10.1016\/j.urolonc.2013.07.016","volume":"32","author":"Q Hu","year":"2014","unstructured":"Hu, Q. et al. The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis. Urol. Oncol. 32(1), 50.e1\u20138 (2014).","journal-title":"Urol. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54219-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54219-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54219-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:43:10Z","timestamp":1785796990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54219-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54219"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54219-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approvals for this study were provided by the Institutional Review Board of Wuhan Union Hospital, the Institutional Review Board of the Second Affiliated Hospital of Fujian Medical University, and the Institutional Review Board of Jiangsu Provincial People\u2019s Hospital. The ethics committees of all three institutions independently reviewed the study protocol and granted waivers for informed consent due to its retrospective nature.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study utilized de-identified patient data, and the requirement for informed consent was waived by three institutional review boards.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23900"}}